US equities
|
MU
$1,085.41
▼-0.24%
META
$722.74
▲+0.20%
NVDA
$234.51
▼-1.25%
PLTR
$202.80
▲+4.47%
GOOGL
$354.43
▲+1.12%
SNDK
$1,671.03
▼-1.26%
AMD
$637.26
▼-1.33%
INTC
$110.59
▼-2.23%
MU
$1,085.41
▼-0.24%
META
$722.74
▲+0.20%
NVDA
$234.51
▼-1.25%
PLTR
$202.80
▲+4.47%
GOOGL
$354.43
▲+1.12%
SNDK
$1,671.03
▼-1.26%
AMD
$637.26
▼-1.33%
INTC
$110.59
▼-2.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about William Collier
Recent news which mentions William Collier
Lab Notes: Arbutus begins human testing of potential hepatitis B cure
March 24, 2023
Tickers
INNO
Tags
Arbutus Biopharma Corporation
Inno
Insurance
From
Business Journals
Lab Notes: FDA approves Incyte's vitiligo treatment; Neuronetics gets a 'big win'
July 22, 2022
Tickers
INNO
Tags
Nabriva Therapeutics plc Ireland
Inno
Keith J/Sullivan
From
Business Journals
Bucks County biopharm firm files lawsuit against Moderna over Covid-19 vaccine
February 28, 2022
Tags
Insurance
Health Care
William Collier
From
Business Journals